Brain abnormalities in survivors of COVID-19 after 2-year recovery: a functional MRI study
The Lancet Regional Health - Western Pacific · 2024-06 · 47 · 101086
DOI: 10.1016/j.lanwpc.2024.101086 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Regional Health - Western Pacific, 2024-06. Verfasst von Yimiao Zhao und 28 weiteren Autor:innen. Beteiligte Einrichtung: National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing 100191, China. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Peking University, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Background
A variety of symptoms, particularly cognitive, psychiatric and neurological symptoms, may persist for a long time among individuals recovering from COVID-19. However, the underlying mechanism of these brain abnormalities remains unclear. This study aimed to investigate the long-term neuroimaging effects of COVID-19 infection on brain functional activities using resting-state functional magnetic resonance imaging (rs-fMRI).
Methods
Fifty-two survivors 27 months after infection (mild-moderate group: 25 participants, severe-critical: 27 participants), from our previous community participants, along with 35 healthy controls, were recruited to undergo fMRI scans and comprehensive cognitive function measurements. Participants were evaluated by subjective assessment of Cognitive Failures Questionnaire-14 (CFQ-14) and Fatigue Scale-14 (FS-14), and objective assessment of Montreal Cognitive Assessment (MoCA), N-back, and Simple Reaction Time (SRT). Each had rs-fMRI at 3T. Measures such as the amplitude of low-frequency fluctuation (ALFF), fractional amplitude of low-frequency fluctuations (fALFF), and regional homogeneity (ReHo) were calculated.
Findings
Compared with healthy controls, survivors of mild-moderate acute symptoms group and severe-critical group had a significantly higher score of cognitive complains involving cognitive failure and mental fatigue. However, there was no difference of cognitive complaints between two groups of COVID-19 survivors. The performance of three groups was similar on the score of MoCA, N-back and SRT. The rs-fMRI results showed that COVID-19 survivors exhibited significantly increased ALFF values in the left putamen (PUT.L), right inferior temporal gyrus (ITG.R) and right pallidum (PAL.R), while decreased ALFF values were observed in the right superior parietal gyrus (SPG.R) and left superior temporal gyrus (STG.L). Additionally, decreased ReHo values in the right precentral gyrus (PreCG.R), left postcentral gyrus (PoCG.L), left calcarine fissure and surrounding cortex (CAL.L) and left superior temporal gyrus (STG.L). Furthermore, significant negative correlations between the ReHo values in the STG.L, and CFQ-14 and mental fatigue were found.
Interpretation
This long-term study suggests that individuals recovering from COVID-19 continue to experience cognitive complaints, psychiatric and neurological symptoms, and brain functional alteration. The rs-fMRI results indicated that the changes in brain function in regions such as the putamen, temporal lobe, and superior parietal gyrus may contribute to cognitive complaints in individuals with long COVID even after 2-year infection. Funding: The National Programs for Brain Science and Brain-like Intelligence Technology of China, the National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality of China, and the National Key Research and Development Program of China.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing 100191, China.
- School of Public Health, Peking University, Beijing 100191, China.
- Institute of Mental Health, National Clinical Research Center for Mental Disorders, Key Laboratory of Mental Health and Peking University Sixth Hospital, Peking University, Beijing 100191, China.
- Peking-Tsinghua Center for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, Beijing 100191, China.
- Wuhan Wuchang Hospital, Wuhan University of Science and Technology, Wuhan, Hubei Province 430063, China.
- The Third Hospital of Wuhan City, Wuhan, Hubei Province 430000, China.
Förderung
- Peking University
- National Key Research and Development Program of China
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Zhao, Y., Liang, Q., Jiang, Z., Mei, H., Zeng, N., Su, S., Wu, S., Ge, Y., Li, P., Lin, X., Yuan, K., Shi, L., Yan, W., Liu, X., Sun, J., Liu, W., van Wingen, G., Gao, Y., Tan, Y., …, & Bao, Y. (2024). Brain abnormalities in survivors of COVID-19 after 2-year recovery: a functional MRI study. The Lancet Regional Health - Western Pacific, 47, 101086. https://doi.org/10.1016/j.lanwpc.2024.101086
Vancouver
Zhao Y, Liang Q, Jiang Z, Mei H, Zeng N, Su S, et al. Brain abnormalities in survivors of COVID-19 after 2-year recovery: a functional MRI study. The Lancet Regional Health - Western Pacific. 2024;47:101086. doi:10.1016/j.lanwpc.2024.101086
BibTeX
@article{Zhao2024,
author = {Zhao, Yimiao and Liang, Qiongdan and Jiang, Zhendong and Mei, Huan and Zeng, Na and Su, Sizhen and Wu, Shanshan and Ge, Yinghong and Li, Peng and Lin, Xiao and Yuan, Kai and Shi, Le and Yan, Wei and Liu, Xiaoxing and Sun, Jie and Liu, Weijian and van Wingen, Guido and Gao, Yujun and Tan, Yiqing and Hong, Yi and Lu, Yu and Wu, Ping and Zhang, Xiujun and Wang, Yongxiang and Shi, Jie and Wang, Yumei and Lu, Lin and Li, Xiangyou and Bao, Yanping},
title = {Brain abnormalities in survivors of COVID-19 after 2-year recovery: a functional MRI study},
journal = {The Lancet Regional Health - Western Pacific},
year = {2024},
volume = {47},
pages = {101086},
doi = {10.1016/j.lanwpc.2024.101086}
}
EUVIMED